NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of JELD-WEN Holding, Inc. (NYSE:JELD), Nathan's Famous, Inc. (NASDAQ:NATH), Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), RBC Bearings Incorporated (NASDAQ:ROLL), Malibu Boats, Inc. (NASDAQ:MBUU), and United Therapeutics Corporation (NASDAQ:UTHR), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
JELD DOWNLOAD: http://Fundamental-Markets.com/register/?so=JELD
NATH DOWNLOAD: http://Fundamental-Markets.com/register/?so=NATH
AERI DOWNLOAD: http://Fundamental-Markets.com/register/?so=AERI
ROLL DOWNLOAD: http://Fundamental-Markets.com/register/?so=ROLL
MBUU DOWNLOAD: http://Fundamental-Markets.com/register/?so=MBUU
UTHR DOWNLOAD: http://Fundamental-Markets.com/register/?so=UTHR
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine JELD-WEN Holding, Inc. (NYSE:JELD), Nathan's Famous, Inc. (NASDAQ:NATH), Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), RBC Bearings Incorporated (NASDAQ:ROLL), Malibu Boats, Inc. (NASDAQ:MBUU), and United Therapeutics Corporation (NASDAQ:UTHR) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed March 19th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
JELD-WEN HOLDING, INC. (JELD) REPORT OVERVIEW
JELD-WEN Holding's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, JELD-WEN Holding reported revenue of $976.00MM vs $973.17MM (up 0.29%) and basic earnings per share -$0.89 vs -$1.69. For the twelve months ended December 31st, 2017 vs December 31st, 2016, JELD-WEN Holding reported revenue of $3,763.93MM vs $3,666.80MM (up 2.65%) and basic earnings per share $0.00 vs -$1.08. JELD-WEN Holding is expected to report earnings on May 11th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.05. The estimated EPS forecast for the next fiscal year is $2.67 and is expected to report on February 20th, 2019.
To read the full JELD-WEN Holding, Inc. (JELD) report, download it here: http://Fundamental-Markets.com/register/?so=JELD
-----------------------------------------
NATHAN'S FAMOUS, INC. (NATH) REPORT OVERVIEW
Nathan's Famous' Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Nathan's Famous reported revenue of $22.08MM vs $19.94MM (up 10.76%) and basic earnings per share -$0.90 vs $0.17. For the twelve months ended March 31st, 2017 vs March 31st, 2016, Nathan's Famous reported revenue of $96.65MM vs $100.89MM (down 4.20%) and basic earnings per share $1.79 vs $1.38 (up 29.71%). Nathan's Famous is expected to report earnings on June 8th, 2018. The report will be for the fiscal period ending March 31st, 2018.
To read the full Nathan's Famous, Inc. (NATH) report, download it here: http://Fundamental-Markets.com/register/?so=NATH
-----------------------------------------
AERIE PHARMACEUTICALS, INC. (AERI) REPORT OVERVIEW
Aerie Pharmaceuticals' Recent Financial Performance
Aerie Pharmaceuticals is expected to report earnings on May 1st, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.76. The estimated EPS forecast for the next fiscal year is -$1.65 and is expected to report on February 27th, 2019.
To read the full Aerie Pharmaceuticals, Inc. (AERI) report, download it here: http://Fundamental-Markets.com/register/?so=AERI
-----------------------------------------
RBC BEARINGS INCORPORATED (ROLL) REPORT OVERVIEW
RBC Bearings' Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, RBC Bearings reported revenue of $166.86MM vs $146.66MM (up 13.78%) and basic earnings per share $0.99 vs $0.54 (up 83.33%). For the twelve months ended March 31st, 2017 vs March 31st, 2016, RBC Bearings reported revenue of $615.39MM vs $597.47MM (up 3.00%) and basic earnings per share $3.00 vs $2.75 (up 9.09%). RBC Bearings is expected to report earnings on May 30th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.90. The estimated EPS forecast for the next fiscal year is $4.68 and is expected to report on May 30th, 2018.
To read the full RBC Bearings Incorporated (ROLL) report, download it here: http://Fundamental-Markets.com/register/?so=ROLL
-----------------------------------------
MALIBU BOATS, INC. (MBUU) REPORT OVERVIEW
Malibu Boats' Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Malibu Boats reported revenue of $114.37MM vs $67.66MM (up 69.04%) and basic earnings per share -$0.31 vs $0.39. For the twelve months ended June 30th, 2017 vs June 30th, 2016, Malibu Boats reported revenue of $281.94MM vs $252.97MM (up 11.45%) and basic earnings per share $1.60 vs $1.01 (up 58.42%). Malibu Boats is expected to report earnings on May 2nd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.48. The estimated EPS forecast for the next fiscal year is $2.57 and is expected to report on September 6th, 2018.
To read the full Malibu Boats, Inc. (MBUU) report, download it here: http://Fundamental-Markets.com/register/?so=MBUU
-----------------------------------------
UNITED THERAPEUTICS CORPORATION (UTHR) REPORT OVERVIEW
United Therapeutics' Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, United Therapeutics reported revenue of $464.70MM vs $409.00MM (up 13.62%) and basic earnings per share $0.37 vs $2.70 (down 86.30%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, United Therapeutics reported revenue of $1,725.30MM vs $1,598.80MM (up 7.91%) and basic earnings per share $9.50 vs $16.29 (down 41.68%). United Therapeutics is expected to report earnings on April 25th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $3.89. The estimated EPS forecast for the next fiscal year is $10.83 and is expected to report on February 20th, 2019.
To read the full United Therapeutics Corporation (UTHR) report, download it here: http://Fundamental-Markets.com/register/?so=UTHR
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.